University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 25 of 27

COMPLETED Phase 2

Acupressure for Post-Treatment Cancer Fatigue

NCT00959998

COMPLETED NA

A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos

NCT01084421

COMPLETED Phase 4

Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4

NCT00538512

COMPLETED NA

A Community-based Participatory Research (CBPR) Intervention for Childhood Asthma Using Air Filters and Air Conditioners

NCT00839046

COMPLETED NA

Dietary Fatty Acid Composition and Obesity-related Metabolic Abnormalities

NCT01451970

COMPLETED NA

An Intervention of Electrical Stimulation in Osteoarthritis

NCT00500448

COMPLETED NA

Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography

NCT00724516

COMPLETED NA

Parameters of Exercise to Prevent Osteoporosis

NCT04063813

COMPLETED

Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis

NCT00668473

COMPLETED NA

Healthy Eating for Colon Cancer Prevention

NCT00475722

COMPLETED

Lay Theories of Health in Young and Middle Aged American Adults

NCT00458172

COMPLETED Phase 1

Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)

NCT00580593

COMPLETED NA

Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care

NCT00508508

COMPLETED Phase 2

Ginger for Colorectal Cancer Prevention

NCT01344538

COMPLETED NA

The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance

NCT00440024

COMPLETED Phase 4

Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)

NCT00663403

COMPLETED Phase 1

Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome

NCT00907127

COMPLETED

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

NCT01030003

COMPLETED

Sleep and Behavior in Children With Cleft Palate

NCT01046591

COMPLETED

Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study

NCT00396123

COMPLETED NA

Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus

NCT00723671

COMPLETED

Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath

NCT00722813

COMPLETED

Apoptic Biomarkers of Periodontal Disease

NCT00569075

COMPLETED NA

Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission

NCT00490633

COMPLETED NA

Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy

NCT00380419

COMPLETED Phase 2

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

NCT00630838

COMPLETED Phase 2

Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer

NCT01825642

COMPLETED NA

Web-based Education to Enhance Fibromyalgia Management

NCT00423631

COMPLETED Phase 2

Microdermabrasion for Acne

NCT00355485

COMPLETED NA

The Fruit and Vegetable Study

NCT00468156

COMPLETED

Organization of Excitation in People With Atrial Fibrillation

NCT00871390

COMPLETED NA

Exercise Plus Activity Strategy Training for Osteoarthritis

NCT00613678

COMPLETED

Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease

NCT00736671

COMPLETED NA

Presurgical Planning With Functional MRI (fMRI) Mapping of Motor Cortex in Patients With Cerebral Tumors

NCT00724737

COMPLETED

ADMA Levels in End-Stage Renal Disease

NCT00350974

TERMINATED NA

Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide

NCT00356265

COMPLETED Early Phase 1

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

NCT00723463

COMPLETED Phase 2

Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer

NCT01824329

COMPLETED

Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer

NCT02289053

COMPLETED Early Phase 1

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

NCT00722059

COMPLETED

Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease

NCT00737217

COMPLETED NA

Treadmill Training and Orthotic Use in Infants With Down Syndrome

NCT00825175

COMPLETED NA

Improving Care for Patients With Bipolar Disorder

NCT00222755

COMPLETED

Preventive Health Practices in Women

NCT00724399

COMPLETED Phase 4

Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms

NCT00318006

COMPLETED NA

Project Health Link: Connecting Patients With Services

NCT00234221

COMPLETED Phase 2

Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis

NCT00242164

COMPLETED NA

Project Health Link: Connecting Patients With Services

NCT00251173

COMPLETED

Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT00281242

COMPLETED

T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT00281229

← Previous Page 25 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.